Cargando…

Five-Year Examination of Utilization and Drug Cost Outcomes Associated with Benefit Design Changes Including Reference Pricing for Proton Pump Inhibitors in a State Employee Health Plan

Detalles Bibliográficos
Autor principal:	Johnson, Jill
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438188/ https://www.ncbi.nlm.nih.gov/pubmed/21434697 http://dx.doi.org/10.18553/jmcp.2011.17.3.200

Ejemplares similares

Effects on the Cost and Utilization of Proton Pump Inhibitors From Adding Over-the Counter Omeprazole to Drug Benefit Coverage in a State Employee Health Plan
por: Harris, Brittany N., et al.
Publicado: (2004)

A 30-Month Evaluation of the Effects on the Cost and Utilization of Proton Pump Inhibitors From Adding Omeprazole OTC to Drug Benefit Coverage in a State Employee Health Plan
por: West, Donna S., et al.
Publicado: (2006)

Effect of a Therapeutic Maximum Allowable Cost (MAC) Program on the Cost and Utilization of Proton Pump Inhibitors in an Employer-Sponsored Drug Plan in Canada
por: Mabasa, Vincent, et al.
Publicado: (2006)

Pharmacy Benefit Manager Pricing and Spread Pricing for High-Utilization Generic Drugs
por: Mattingly, T. Joseph, et al.
Publicado: (2023)

The Rising Cost of Insulin for Pump Users: How Policy Drives Prices
por: Brown-Georgi, Julia, et al.
Publicado: (2020)

Inhibiting the proton pump: mechanisms, benefits, harms, and questions
por: Aronson, Jeffrey K.
Publicado: (2016)

The impact of external reference pricing on pharmaceutical costs and market dynamics
por: Voehler, Dominic, et al.
Publicado: (2023)

Estimating Drug Costs: How do Manufacturer Net Prices Compare with Other Common US Price References?
por: Mattingly, T. Joseph, et al.
Publicado: (2018)

When the Price Is Right: Beyond the Medical Risks and Benefits of Costly Therapies
por: Kittleson, Michelle M.
Publicado: (2022)

Cost-benefit analysis in educational planning
por: Woodhall, Maureen
Publicado: (1992)

Prescribing patterns and economic costs of proton pump inhibitors in Colombia
por: Machado-Alba, Jorge, et al.
Publicado: (2013)

Influence of generic reference pricing on medicine cost in Slovenia: a retrospective study
por: Marđetko, Nika, et al.
Publicado: (2018)

Protons pump inhibitor treatment and lower gastrointestinal bleeding: Balancing risks and benefits
por: Lué, Alberto, et al.
Publicado: (2016)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Employee Benefits Design and Planning: A Guide to Understanding Accounting, Finance, and Tax Implications
por: Biswas, Bashker
Publicado: (2014)

The Medical Examination of Employees
Publicado: (1908)

The Medical Examination of Employees
por: Langwill, H. G.
Publicado: (1911)

The Medical Examination of Employees
por: Langwill, H. G.
Publicado: (1911)

Physical Examinations of Employees
Publicado: (1914)

The impact of reference pricing and extension of generic substitution on the daily cost of antipsychotic medication in Finland
por: Koskinen, Hanna, et al.
Publicado: (2014)

Proton pump inhibitors: potential cost reductions by applying prescribing guidelines
por: Cahir, Caitriona, et al.
Publicado: (2012)

The costly case of proton-pump inhibitors: a single-center experience
por: Suresh Kumar, Vishnu Charan, et al.
Publicado: (2020)

The Handbook of Employee Benefits: Health and Group Benefits
por: Rosenbloom, Jerry
Publicado: (2011)

Pricing and Cost Accounting
por: Oyer, Darrell
Publicado: (2011)

Cost-Based Pricing
por: Oyer, Darrell
Publicado: (2012)

Coprescribing proton-pump inhibitors with nonsteroidal anti-inflammatory drugs: risks versus benefits
por: Gwee, Kok Ann, et al.
Publicado: (2018)

Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China
por: Zhang, Yichen, et al.
Publicado: (2022)

Measuring the Benefits of Employee Engagement
por: Kumar, V
Publicado: (2015)

Impact of Generic Price Linkage System and Reference Price System on prices of pharmaceuticals – comparison of Austria and Finland
por: Martikainen, Jaana E, et al.
Publicado: (2015)

Proton-pump inhibitors among adults: a nationwide drug-utilization study
por: Hálfdánarson, Óskar Ö., et al.
Publicado: (2018)

When Everyone Wins? Exploring Employee and Customer Preferences for No-Haggle Pricing
por: Kniffin, Kevin M., et al.
Publicado: (2018)

Comparison of health care resource utilization and costs among patients with GERD on once-daily or twice-daily proton pump inhibitor therapy
por: Mody, Reema, et al.
Publicado: (2013)

Ecosystem Services in Conservation Planning: Targeted Benefits vs. Co-Benefits or Costs?
por: Chan, Kai M. A., et al.
Publicado: (2011)

Effect of Carving in Pharmacy Benefits on Utilization and Costs
por: Parekh, Natasha, et al.
Publicado: (2020)

Impact of variable electricity price on heat pump operated buildings
por: Mascherbauer, Philipp, et al.
Publicado: (2022)

Does Helicobacter pylori eradication or proton pump inhibitor use benefit gastroesophageal reflux disease?
por: Sakin, Yusuf Serdar, et al.
Publicado: (2015)

Pathophysiological Studies Are Mandatory to Understand the Benefit of Proton Pump Inhibitors in Patients with Idiopathic Pulmonary Fibrosis
por: Savarino, Edoardo, et al.
Publicado: (2016)

Finding the Truth About Health Care Cost Drivers - Price Versus Utilization Factors
por: Curtiss, Frederic R.
Publicado: (2003)

Preliminary Examination of an Appropriate Price Calculation Method and Medical Treatment Costs for Foreign Visitors in Japan
por: Takura, Tomoyuki
Publicado: (2021)

Employee and Employer Benefits From a Migraine Management Program: Disease Outcomes and Cost Analysis
por: Schaetz, Leonhard, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cvft1f0m0afhai9l4noafvqulq